Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

enVVeno Medical (NVNO) Current Deferred Revenue (2017 - 2020)

enVVeno Medical has reported Current Deferred Revenue over the past 4 years, most recently at $33000.0 for Q3 2020.

  • Quarterly results put Current Deferred Revenue at $33000.0 for Q3 2020, changed 0.0% from a year ago — trailing twelve months through Sep 2020 was $33000.0 (changed 0.0% YoY), and the annual figure for FY2019 was $33000.0, changed 0.0%.
  • Current Deferred Revenue for Q3 2020 was $33000.0 at enVVeno Medical, roughly flat from $33000.0 in the prior quarter.
  • Over the last five years, Current Deferred Revenue for NVNO hit a ceiling of $103400.0 in Q4 2017 and a floor of $33000.0 in Q4 2018.
  • Median Current Deferred Revenue over the past 4 years was $33000.0 (2018), compared with a mean of $41072.7.
  • Biggest five-year swings in Current Deferred Revenue: tumbled 68.09% in 2018 and later changed 0.0% in 2019.
  • enVVeno Medical's Current Deferred Revenue stood at $103400.0 in 2017, then tumbled by 68.09% to $33000.0 in 2018, then changed by 0.0% to $33000.0 in 2019, then changed by 0.0% to $33000.0 in 2020.
  • The last three reported values for Current Deferred Revenue were $33000.0 (Q3 2020), $33000.0 (Q2 2020), and $33000.0 (Q1 2020) per Business Quant data.